bf/NASDAQ:BNGO_icon.jpeg

NASDAQ:BNGO

Bionano Genomics, Inc.

  • Stock

USD

Last Close

1.11

17/05 20:00

Market Cap

47.39M

Beta: 2.26

Volume Today

865.05K

Avg: 7.20M

PE Ratio

−0.17

PFCF: −0.32

Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.46
-
0.94
103.96%
0.48
48.36%
0.34
30.70%
0.14
58.05%
0.05
66.10%
0.09
89.61%
0.17
86.31%
cash conversion cycle
201.73
-
91.85
54.47%
125.44
36.56%
268.38
113.95%
143.71
46.45%
169.78
18.14%
379.87
123.74%
269.61
29.03%
cash per share
10.04
-
3.78
62.33%
16.43
334.33%
0.51
96.93%
0.37
26.98%
0.91
145.51%
0.39
56.78%
2.98
662.35%
company equity multiplier
-0.54
-
-0.20
62.77%
2.45
1,311.30%
8.36
241.66%
1.72
79.39%
1.12
35.08%
1.23
10.23%
2.23
80.84%
days of inventory outstanding
183.32
-
102.51
44.08%
44.77
56.33%
185.71
314.79%
211.20
13.73%
320.50
51.75%
496.99
55.07%
314.72
36.67%
days of payables outstanding
80.81
-
139.39
72.48%
56.64
59.37%
145.56
157.01%
186.61
28.20%
250.87
34.43%
209.31
16.57%
142.76
31.80%
days of sales outstanding
99.22
-
128.73
29.74%
137.30
6.66%
228.23
66.23%
119.12
47.81%
100.16
15.92%
92.19
7.96%
97.64
5.91%
dividend yield
ebit per revenue
-3.12
-
-2.44
21.61%
-1.70
30.36%
-2.55
50.16%
-4.53
77.49%
-4.29
5.42%
-4.74
10.47%
-3.86
18.50%
ebt per ebit
0.89
-
1.01
13.00%
0.91
9.97%
1.15
27.29%
1.07
7.46%
1.01
4.94%
0.99
2.08%
1.67
67.96%
effective tax rate
-0.00
-
-0.00
15.81%
-0.00
5.62%
-0.00
15.89%
-0.00
0.60%
0.07
10,400.50%
-0.01
119.70%
-0.00
98.15%
enterprise value multiple
-1.66
-
-1.04
36.99%
-2.14
105.45%
-16.53
671.40%
-82.72
400.40%
-107.40
29.85%
-32.43
69.81%
-0.79
97.56%
fixed asset turnover
1.68
-
3.16
88.64%
6.75
113.53%
5.20
23.05%
1.73
66.67%
0.86
50.40%
0.96
11.78%
1.11
15.81%
free cash flow per share
-47.53
-
-80.84
70.08%
-20.16
75.06%
-0.86
95.72%
-0.37
57.43%
-0.27
27.86%
-0.44
67.08%
-3.85
768.53%
gross profit margin
0.47
-
0.37
22.74%
0.27
25.02%
0.33
21.06%
0.33
1.73%
0.22
33.93%
0.21
0.75%
0.26
23.87%
interest coverage
-45.03
-
-39.29
12.75%
-14.78
62.38%
-11.32
23.44%
-15.30
35.23%
-83.17
443.44%
-441.94
431.35%
-27.24
93.84%
inventory turnover
1.99
-
3.56
78.82%
8.15
128.97%
1.97
75.89%
1.73
12.07%
1.14
34.10%
0.73
35.51%
1.16
57.91%
long term debt to capitalization
-0.29
-
0.47
-
0.32
-
0.03
91.87%
0.04
36.75%
0.07
96.76%
net income per ebt
1.00
-
1.00
0.01%
1.00
0.00%
1.00
0.01%
1.00
0.00%
0.93
7.38%
1.01
9.45%
1.00
1.39%
net profit margin
-2.77
-
-2.46
11.41%
-1.54
37.30%
-2.95
91.11%
-4.84
64.24%
-4.03
16.73%
-4.77
18.39%
-6.44
34.98%
operating cash flow per share
-44.95
-
-77.07
71.47%
-19.83
74.27%
-0.86
95.66%
-0.37
57.34%
-0.26
29.29%
-0.43
66.07%
-3.80
780.03%
operating cycle
282.54
-
231.24
18.16%
182.07
21.26%
413.94
127.35%
330.33
20.20%
420.65
27.34%
589.18
40.06%
412.36
30.01%
operating profit margin
-3.12
-
-2.44
21.61%
-1.70
30.36%
-2.55
50.16%
-4.53
77.49%
-4.29
5.42%
-4.74
10.47%
-3.86
18.50%
payables turnover
4.52
-
2.62
42.02%
6.44
146.11%
2.51
61.09%
1.96
22.00%
1.45
25.61%
1.74
19.86%
2.56
46.62%
pretax profit margin
-2.77
-
-2.46
11.42%
-1.54
37.30%
-2.94
91.13%
-4.83
64.24%
-4.35
10.09%
-4.70
8.17%
-6.44
36.88%
price fair value
-1.18
-
-0.33
71.96%
5.20
1,671.53%
117.61
2,162.80%
91.53
22.18%
24.55
73.18%
16.93
31.03%
0.67
96.04%
receivables turnover
3.68
-
2.84
22.92%
2.66
6.25%
1.60
39.84%
3.06
91.60%
3.64
18.94%
3.96
8.64%
3.74
5.58%
return on assets
-1.27
-
-2.30
80.69%
-0.75
67.62%
-0.99
32.44%
-0.68
31.10%
-0.19
71.77%
-0.43
124.49%
-1.08
151.47%
return on capital employed
-3.90
-
3.57
191.43%
-1.01
128.21%
-6.63
558.55%
-0.75
88.71%
-0.22
71.00%
-0.48
123.41%
-1.22
151.42%
return on equity
0.69
-
0.47
32.72%
-1.82
492.22%
-8.26
352.51%
-1.17
85.80%
-0.21
81.68%
-0.53
147.44%
-2.42
354.77%
total debt to capitalization
-0.32
-
-0.15
51.89%
0.47
404.49%
0.85
79.82%
0.32
62.51%
0.03
90.32%
0.04
45.34%
0.48
968.84%

All numbers in USD (except ratios and percentages)